Skip to main content
The Malaysian Journal of Medical Sciences : MJMS logoLink to The Malaysian Journal of Medical Sciences : MJMS
. 2018 Feb 28;25(1):84–95. doi: 10.21315/mjms2018.25.1.10

Clinical and Sociodemographic Predictors of the Quality of Life among Patients with Type 2 Diabetes Mellitus on the East Coast of Peninsular Malaysia

Zaleha Jusoh 1, Hizlinda Tohid 2,, Khairani Omar 2, Noor Azimah Muhammad 2, Saharuddin Ahmad 2
PMCID: PMC5862054  PMID: 29599638

Abstract

Background

The quality of life (QoL) describes the multidimensional self-perceived well-being of a person, which is an important diabetes outcome. This study aimed to measure the QoL scores among patients with type 2 diabetes mellitus (T2DM), as well as their clinical and sociodemographic predictors.

Methods

This cross-sectional study involved 180 randomly sampled patients at a primary care clinic on the East Coast of Peninsular Malaysia. A self-administered questionnaire containing the Audit of Diabetes Dependent Quality of Life-18 (ADDQoL-18) was used.

Results

Most of the respondents (96.7%) were Malay, with a median (interquartile range, IQR) age of 54.0 (14.0) years old. The majority of them were females (60.0%), married (81.1%) and from low-income families (63.3%), who attained a secondary education or lower (75.6%). Only 49.4% of them were employed. The mean (standard deviation, SD) ADDQoL-18 average weighted impact score was −4.58 (2.21) and all 18 domains were negatively affected, particularly the living condition, family life and working life. The multiple linear regression analysis showed that the age (adjusted B = 0.05, P = 0.004) and insulin use (adjusted B = −0.84, P = 0.011) were QoL predictors.

Conclusion

T2DM negatively impacts the patient’s QoL in all aspects of their life. The QoL improvement with age suggests that the older patients had accepted and adapted to their illness. The need to improve the QoL among insulin users was also highlighted.

Keywords: diabetes mellitus, quality of life, Malaysia, insulin, age

Introduction

The general aim of diabetes care is to achieve good biopsychosocial outcomes. Having good glycaemic control and reducing the risk of diabetes complications must be achieved in tandem with preserving the patient’s quality of life (QoL) (1, 2). The QoL has become an important measure in diabetes management because the treatment itself may affect the patient’s physical and psychosocial well-being (2, 3).

The QoL describes the multidimensional self-perceived well-being of a person, and it includes the general well-being, physical health and functioning, mental health and emotional functioning, social functioning and satisfaction with treatment (1, 2, 4). It is usually regarded as a synonym for the health status and satisfaction (4), and it reflects the patient’s satisfaction with regard to how well their needs and expectations are met. Therefore, it is influenced by the patient’s personal goals and life concerns (5). The QoL is also shaped by the patient’s culture, social context, environment, values, belief system and tendency toward acceptance (5, 6).

Generally, individuals with type 2 diabetes mellitus (T2DM) have poorer QoLs when compared to those who are healthy (1, 7). The QoLs among patients with T2DM can be negatively affected to various degrees and in various domains of life (813). Nevertheless, different studies have used different tools to measure the QoL, and thus, it is difficult to compare and generate conclusions from these findings (1, 2, 7, 14).

Various sociodemographic and diabetes-related factors have been found to affect the QoL of patients with T2DM. These include the diabetes severity (indirectly indicated by the duration of diabetes, glycaemic control and number of complications), co-morbidities, treatment types (insulin use versus non-insulin use), treatment compliance and hypoglycaemic episodes (1, 7, 10, 1517).

In Malaysia, studies examining the QoL predictors among patients with T2DM are still needed (1113, 1820). By identifying these determinants, more focused strategies to improve the health outcomes of diabetes management could be implemented, and these outcomes include the QoL. Therefore, this study aimed to measure the QoL scores among patients with T2DM at a primary care clinic on the East Coast of Peninsular Malaysia. The QoL score predictors among the respondents were also determined.

Materials and Methods

This cross-sectional study was conducted at a primary care clinic on the East Coast of Peninsular Malaysia. This clinic provides a structured programme for patients with T2DM run by a trained diabetes team. It is the referral centre for fundus camera examinations from other clinics under the jurisdiction of the District Health Office of Administration.

Prior to the data collection period (October 2011 until January 2012), there were 1,722 registered diabetes patients in this clinic. These registered patients were randomly selected through a computer-generated list of random numbers. Their diabetes records were retrieved, and their criteria for participation were examined. The inclusion criteria for this study were adult patients older than 18 years who had been diagnosed with T2DM for more than one year. Those who were unable to read or understand Bahasa Malaysia or had cognitive impairments, substance abuse disorders, and non-diabetes related co-morbidities that could affect their QoLs were excluded. Those patients who met the criteria were contacted via the telephone. Those who agreed to participate were given appointments to meet the researchers at the clinic.

Audit of Diabetes Dependent Quality of Life

In this study, the Audit of Diabetes Dependent Quality of Life-18 (ADDQoL-18) was used. It is a diabetes-specific measurement of the QoL that was developed by Bradley et al. (21). The ADDQoL-18 has been widely used due to its good psychometric properties (2), and it was translated to the Malay language (i.e. Bahasa Malaysia) and validated by Kamarul Imran et al. (13). The Cronbach’s alpha of the Bahasa Malaysia version of the ADDQoL-18 was 0.943.

The ADDQoL-18 contains 18 items assessing the condition-specific domains of life (Table 1) (21). These specific items were assessed by asking the respondents to rate the impacts on 18 specific conditions if they did not have diabetes. The response options used a seven-point Likert scale, ranging from −3 (very much better) to +3 (very much worse). However, three of the condition-specific domains of life, the ‘working life and work-related opportunities’, ‘family life’ and ‘sex life’, had ‘not applicable’ options. Thus, if the respondents felt that these items were not applicable to them, the items were not included in the final score. All the applicable domains of life were weighted according to the importance perceived by the respondents. This importance rating ranged from 0 (not at all important) to 3 (very important).

Table 1.

Domains of ADDQOL-18

General QOL Domain 1. Present QOL
2. If I did not have diabetes
Condition-specific domains of life 3. Working life and work related opportunitiesa
4. Family lifea
5. Friendships and social life
6. Sex lifea
7. Physical appearance
8. Physical activities
9. Holidays and leisure activities
10. Ease of travelling (local or long distance)
11. Confidence in ability to do things
12. Motivation to achieve things
13. The way society reacts to me
14. Worries about the future
15. Finances
16. Unwanted dependence on others
17. Living condition
18. Freedom to eat as I wish
19. Enjoyment of food
20. Freedom to drink as I wish
a

Domains that have a ‘not applicable’ option

For each domain, the impact and importance ratings were multiplied to calculate the weighted impact rating. Subsequently, the final average weighted impact (AWI) score was calculated by dividing the sum of the weighted impact ratings by the number of applicable domains. This AWI score ranged from −9 (maximum negative impact of diabetes) to +9 (maximum positive impact of diabetes). Thus, more negative scores indicated poorer QoLs due to diabetes (21).

Quality of Life Determinants

The independent variables in this study included the respondents’ sociodemographic factors (age, gender, educational level, monthly family income and living status, i.e., living alone or with others). The other independent variables were clinical factors, including the type of treatment received (non-insulin therapy or insulin therapy), duration of diabetes (< 5 years, 5–10 years or > 10 years), diabetes control (HbA1C ≤ 7% or > 7%), number of diabetes-related complications (0, 1 or ≥ 2) and the presence of diabetes-related hospitalisation. These data were retrieved from the respondents’ medical records.

Statistical Analysis

The data analysis was performed using the IBM SPSS Statistics version 19. A bivariate analysis was done using the Spearman correlation test (for the numerical independent variables), as well as the independent t-test and one-way analysis of variance (ANOVA) (for the categorical independent variables). Subsequently, a multivariate analysis using multiple linear regressions was done to determine the predictors that significantly influenced the respondents’ QoLs.

Ethical Consideration

This study was registered with the National Medical Research Registry (NMRR-11-753-9623). Approvals from the Research and Ethics Committee of the Universiti Kebangsaan Malaysia (FF-333-2011) and the Medical Research Ethics Committee at the Ministry of Health Malaysia were obtained. This study received permission to use the original and Bahasa Malaysia versions of the ADDQoL-18 from the authors. In addition, written informed consent was obtained from each respondent.

Results

Respondents’ Characteristics

There were 180 patients included in this study, and the response rate was 91.8%. Approximately 96.7% of the respondents were Malays, which is the predominant ethnic group on the East Coast of Peninsular Malaysia (Table 2). Their median (interquartile range, IQR) age was 54.0 (13.0) years old. Three-fifths of the participants were females, and 81.1% were married. Only 10.0% of them lived alone. Approximately three-fourths (75.6%) of the respondents had attained a secondary education or lower, and 63.3% came from low-income families. Less than a half of them (49.4%) were employed.

Table 2.

Socio-demographic and diabetes-related characteristics of the participants (n = 180)

Variables n (%) Median (IQR)
Age (year)a 54.0 (13.0)
 Younger adults (20–39 years) 16 (8.9)
 Middle-age adults (40–64 years) 144 (80.0)
 Elderly (≥65 years) 20 (11.1)
Gender
 Male 72 (40.0)
 Female 108 (60.0)
Ethnicity
 Malay 174 (96.7)
 Non-Malay 6 (3.3)
Education level
 No formal or primary education 41 (22.8)
 Secondary education 95 (52.8)
 Tertiary education 44 (24.4)
Employment status
 Employed 89 (49.4)
 Unemployed/Pensioner 91 (50.6)
Monthly family income (RM)a 1500.0 (2250.0)
 Low income (< RM2000) 114 (63.3)
 Middle or high income (≥ RM2000) 66 (36.7)
Marital status
 Married 146 (81.1)
 Non-married 34 (18.9)
Living status
 Stayed alone 18 (10.0)
 Stayed with family or others 162 (90.0)
Duration of diabetes mellitus
 < 5 years 81 (45.0)
 5–10 years 62 (34.4)
 > 10 years 37 (20.6)
Types of diabetic treatment
 Non-insulin use 109 (60.6)
 Insulin use 71 (39.4)
Diabetes controlled (HBA1C)a 8.7 (3.0)
 Controlled (HBA1C ≤ 7%) 32 (17.8)
 Uncontrolled (HBA1C > 7%) 148 (82.2)
Number of diabetes-related complications
 No complication 103 (57.2)
 1 complication 56 (31.1)
 2 and more complications 21 (11.7)
Diabetes-related hospital admission
 No 163 (90.6)
 Yes 17 (9.4)
a

Data was not normally distributed

Approximately 55.0% of the respondents had T2DM for 5 years or more, and 42.8% had at least one diabetes-related complication (Table 2). The glycaemic control was poor in most of them (82.2%); however, only two-fifths (39.4%) were taking insulin. Almost one-tenth (9.4%) had a history of diabetes-related hospitalisation.

Quality of Life of the Respondents

The ADDQoL-18 AWI scores for all the participants in this study were negative. The mean (standard deviation, SD) ADDQoL-18 AWI score was −4.58 (2.21). The mean (SD) ADDQoL-18 weighted impact ratings for the 18 condition-specific domains of life ranged between −2.84 (3.82) and −5.88 (3.07) (Figure 1). Overall, the three most negatively affected domains of life were the living condition, family life and working life (Figure 1).

Figure 1.

Figure 1

The ADDQOL-18 weighted ratings for 18 condition-specific

*Domains that have a ‘not applicable’ option

Bivariate Analysis of the Determinants of the Quality of Life

From the bivariate analysis, the age (r = 0.21, P = 0.004), gender (P = 0.041), living status (P = 0.032), type of treatment (P = 0.003), HbA1C (r = −0.21, P = 0.004), number of diabetes-related complications (P = 0.020) and history of hospitalisation due to diabetes-related illness (P = 0.027) were significantly associated with a lower average weighted ADDQoL-18 (Table 3, Figures 2 and 3). However, there were no associations between the ADDQoL-18 AWI scores and the other variables.

Table 3.

Association of the average weighted ADDQOL-18 scores among participants with their socio-demographic and diabetes-related factors

Variables Mean (SD) or ra P-value*
Agea (n = 180) 0.21 0.004*
Genderb
 Male (n = 72) −4.17 (2.29) 0.041*
 Female (n = 108) −4.86 (2.11)
Ethnicity
 Malay (n = 174) −4.59 (2.21) 0.699
 Non-Malay (n = 6) −4.24 (2.32)
Education levelC
 No formal or primary education (n = 41) −4.09 (2.25) 0.229
 Secondary education (n = 95) −4.79 (2.19)
 Tertiary education (n = 44) −4.59 (2.19)
Employment statusb
 Employed (n = 89) −4.48 (2.24) 0.552
 Unemployed/pension (n = 91) −4.68 (2.18)
Monthly family incomeb
 Low income (< RM2000) (n = 114) −4.54 (2.20) 0.752
 Middle or high income (≥ RM2000) (n = 66) −4.65 (2.24)
Marital statusb
 Married (n = 146) −4.88 (2.13) 0.389
 Non-married (n = 34) −4.51 (2.23)
Living statusb
 Staying with family or others (n = 162) −4.70 (2.20) 0.032*
 Staying alone (n = 18) −3.53 (2.08)
Duration of diabetes mellitus (years)c
 < 5 (n = 81) −4.65 (2.06) 0.700
 5–10 (n = 62) −4.40 (2.45)
 > 10 (n = 37) −4.75 (2.14)
Types of diabetic treatmentb
 Non-insulin use (n = 109) −4.21 (2.30) 0.003*
 Insulin use (n = 71) −5.16 (1.93)
HbA1Ca (n = 180) −0.21 0.004*
Number of diabetes-related complicationsc
 No complication (n = 103) −4.24 (2.36) 0.020*
 1 complication (n = 56) −4.81 (2.02)
 2 or more complications (n = 21) −5.63 (1.50)
History of diabetes-related hospital admissionb
 No (n = 163) −4.47 (2.19) 0.027*
 Yes (n = 17) −5.71 (2.11)
*

Significant level at 0.05

a

Spearman’s rho correlation;

b

Independent t-test; all assumptions met;

c

One-way ANOVA, all assumptions met; post hoc analysis:

Using Scheffe: No/primary education versus Secondary education: P = 0.23; No/primary education versus Tertiary education: P = 0.57; Secondary education versus Tertiary education: P = 0.88

Using Dunnet C: No complication versus 1 complication: P > 0.05; No complication versus 2 complication: P < 0.05; 1 complication versus ≥ 2 complication: P > 0.05

Figure 2.

Figure 2

Correlation between age and the average weighted ADDQOL-18

Spearman’s rho correlation: −0.21, P = 0.004

Figure 3.

Figure 3

Correlation between HbA1C and the average weighted ADDQOL-18

Spearman’s rho correlation: 0.21, P = 0.004

Multivariate Analysis of the Determinants of the Quality of Life

A multiple linear regression using a stepwise model selection was done to identify the predictors of the ADDQoL-18 AWI scores. The independent variables included in the analysis were those found to have P values of < 0.250 (age, gender, education level, living status, type of treatment, number of diabetes-related complications and presence of diabetes-related hospitalisation). Only the age (adjusted B = 0.05, P = 0.004) and insulin use (adjusted B = −0.84, P = 0.011) were found to be predictors of the ADDQoL-18 AWI score after controlling for the gender, educational level, living status, number of diabetes-related complications and presence of diabetes-related hospitalisation (Table 4). An age increase of 10 years led to an increase in the ADDQoL-18 AWI score of 0.5 points, suggesting that younger patients have poorer QoLs when compared to older patients. The ADDQoL-18 AWI scores of the insulin users were lower by 0.8 when compared to the non-insulin users. The model explained 9% of the variance in the ADDQoL-18 AWI scores of the respondents, and the fitness of this model was adequate. The absence of interactions between the predictors was demonstrated (P = 0.08) and there was no problem with multicollinearity [both tolerance values were 0.98, above the value of 1-R2 (0.91 whereby R2 = 0.09); variance inflation factor (VIF) < 10, average VIF = 1.02]. The overall linearity of this model fit reasonably well, and the equal variance of the residual was met.

Table 4.

Factors predicting the ADDQOL-18 average weighted impact score among T2DM patients (n = 180)

Model* SLRa MLRb


b valuec 95% CI P-value adj. bd value 95% CI t-stat P-value
Constant 6.82 8.64, 4.99 7.38 0.00
Age (year) 0.05 0.02, 0.09 0.002 0.05 0.02, 0.08 2.90 0.004
Female vs Male −0.68 −1.34, −0.03 0.041
Secondary education versus No/ primary education −0.45 −1.90, 0.20 0.175
Tertiary education versus No/ primary education −0.01 −0.77, 0.75 0.980
Staying alone versus Staying with others 1.17 0.10, 2.24 0.032
HbA1C (%) −0.22 −0.36, −0.07 0.004
Insulin users versus Non-insulin users −0.96 −1.61, 0.60 0.004 −0.84 −1.48, 0.20 −2.57 0.011
One complication versus No complication −0.34 −1.04, 0.37 0.346
≥2 complications versus No complication −1.18 −2.18, −0.18 0.021
Had hospital admission versus No hospital admission −1.24 −2.34, −0.14 0.027
*

Model only included variables with P < 0.25

a

Simple Linear Regression;

b

Multiple Linear regression using Stepwise method

c

Crude regression coefficient;

d

Adjusted regression coefficient

MLR Final Model: R2: 0.09; Adjusted R2: 0.08; Model F statistic: 8.58, P < 0.001; The model was reasonably fit; No interaction between independent variables; No multicollinearity problem

Discussion

Many previous studies have shown that T2DM can impair the QoLs of these patients (813), and this study has provided additional evidence to support this observation. In fact, all aspects of these patients’ lives were affected by diabetes, as shown previously by other studies (812, 15, 18, 22, 23). These findings indicate that T2DM is undeniably a demanding illness that can impair the sufferer’s well-being. Not only do they have to tolerate the physical symptoms of the disease, its complications and the treatment side-effects, they must also struggle to adjust their lives to accommodate their self-care activities and conform to the recommended management (6).

The mean ADDQoL-18 AWI score and the ADDQoL-18 weighted ratings for all the domains in our study were similar to those of another local study (12). Since both of the studies were carried out on the East Cost of Peninsular Malaysia, the respondents could share similar socioeconomic conditions, cultures and beliefs. However, the QoLs of our respondents appeared to be the worst among the other studies that used the ADDQoL-18 questionnaire (15, 22, 23). As expected, the mean ADDQoL-18 AWI scores of the studies conducted in more developed countries, such as the USA and Ireland, were substantially higher than in the local studies, indicating better QoLs among their patients when compared to the Malaysian patients (12, 15, 22, 23). Even diabetes patients in China suffered lesser impacts than our respondents; their ADDQoL-18 weighted ratings for the 18 condition-specific domains ranged from −1.71 to −3.57, but the ratings among our respondents ranged between −2.84 and −5.88 (9). Different needs, life demands and expectations may be the causes of these various QoL levels because people from different countries have different cultures, socioeconomic conditions, societal beliefs and norms (5, 6). Those from developed countries might even receive more comprehensive and effective support from their advanced healthcare systems (23). This could ease their struggle and improve their well-being.

In this study, a younger age and insulin use were found to be predictors of lower ADDQoL-18 AWI scores after controlling for the confounding factors, which were the gender, education level, living status, number of diabetes-related complications and presence of diabetes-related hospitalisation. Contrary to the popular belief that the QoL deteriorates as we age (7), this current study showed otherwise. This finding was similarly demonstrated by other studies (8, 15, 23), and the lesser emotional distress experienced by older patients has been postulated to explain this finding (8). This is because older patients may have lower work and family demands when compared to younger patients who are still working, and who must take care of their young children and ageing parents (8). Older patients might also have accepted the disease and developed the ability to cope with the demands of a life with diabetes (15). Further studies are required to explore the reasons for this finding. Nevertheless, support should always be given to any patient who is struggling to live with diabetes. Based on this study, younger patients may need more support to adapt to the demands of life with diabetes.

Similar to previous studies, the insulin users were generally found to have poorer QoLs than the non-insulin users (14, 15, 2426). However, some studies have demonstrated that the initiation of insulin did not impair the QoL; in fact, there are studies showing an improvement in the QoL instead (2730). These contradictory findings may be related to the different types of insulin (human insulin versus analogues), delivery systems (multiple injections versus continuous pump) and insulin regimens (‘before bed’ insulin, twice daily insulin or basal bolus insulin) (1, 14). Nevertheless, there are patients who may have difficulties using insulin. One must ensure that they are taking the correct insulin dose, using the right technique and injection timing and storing their insulin properly. In addition, they must be disciplined with their mealtimes to prevent hypoglycaemia. Regular blood glucose self-monitoring is also recommended to help these patients to choose the required insulin dosage. With all of these considerations, some patients may feel that insulin use causes lifestyle restrictions, inconvenience and embarrassment (31). Their lives may become regimented, thus requiring significant adjustments, especially for those who are still working. Therefore, healthcare providers should explore these difficulties in using insulin to identify individualised support that can ease the struggle, such as the use of a simple insulin regimen, insulin analogues or a continuous pump. In addition, counselling that can improve their knowledge of insulin and empower their self-efficacy to deal with the challenges related to insulin use may benefit insulin users.

This study also highlights the possibility of other factors that could predict the QoL, other than the sociodemographic and diabetes-related factors, since the assessed factors could only explain 9% of the variance in the ADDQoL-18 AWI scores of the respondents. Psychosocial problems, healthcare system types and the patient’s spirituality may play significant roles in determining the QoL. For example, depression, anxiety and stress can negatively affect the QoLs of patients with T2DM, and these problems are common among them (3235). Certain diabetes care systems with a structured model of care could also improve their QoLs (23). Lastly, spirituality could enhance the inner strength, hope and acceptance of self-responsibility of these patients, which could influence their QoLs (36, 37). In view of this, future studies should include these factors for a more holistic assessment.

This study was conducted in a primary healthcare clinic on the East Coast of Peninsular Malaysia, and it involved mostly Malays. Because of this, the generalisation of the findings is limited. Furthermore, the findings of this study could not confirm the causal relationships between the predictors and QoLs because it used a cross-sectional design.

Conclusion

T2DM negatively impairs the QoLs of these patients in all aspects of their lives, particularly their living conditions, family lives and working lives. Age and insulin use were found to be the significant predictors of the ADDQoL-18 AWI score. Interestingly, the patients’ QoLs improved as they aged, which suggests that adapting to life with diabetes may play an important role in maintaining their well-being. This study also highlights the needs to improve the QoLs among insulin users, because its use was found to be associated with poorer QoLs when compared to those who did not use insulin. It appears that other important factors, apart from the sociodemographic and diabetes-related factors, such as the duration of diabetes, diabetes control and the presence of diabetes-related complications, may play more significant roles in determining the QoL. Thus, future studies should include all possible factors to determine the best predictors of the QoLs among diabetes patients.

Acknowledgements

The authors would like to thank the Director General of Health Malaysia for permission to publish this paper. Special thanks to the Family Medicine Specialist of the health clinic and all clinic staff who had given their support and assistance. This study was supported by the Universiti Kebangsaan Malaysia (FF-333-2011).

Footnotes

Authors’ Contributions

Conception and design: ZJ, HT, KO

Analysis and interpretation of the data: ZJ, HT, NAM, SA

Drafting of the article: HT

Critical revision of the article for important intellectual content: HT, KO, NAM, SA

Final approval of the article: ZJ, HT, KO, NAM, SA

Provision of study materials or patients: ZJ

Statistical expertise: HT, NAM, SA

Obtaining of funding: KO

Administrative, technical, or logistic support: KO

Collection and assembly of data: ZJ

References

  • 1.Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev. 1999;15(3):205–218. doi: 10.1002/(sici)1520-7560(199905/06)15:3<205::aid-dmrr29>3.0.co;2-o. https://doi.org/10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  • 2.El Achhab Y, Nejjari C, Chikri M, Lyoussi B. Disease-specific health-related quality of life instruments among adults diabetic: A systemic review. Diabetes Res Clin Pract. 2008;80(2):171–184. doi: 10.1016/j.diabres.2007.12.020. https://doi.org/10.1016/j.diabres.2007.12.020. [DOI] [PubMed] [Google Scholar]
  • 3.Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL-18. Qual Life Res. 1999;8(1–2):79–91. doi: 10.1023/a:1026485130100. [DOI] [PubMed] [Google Scholar]
  • 4.Levterova BA, Dimitrova DD, Levterov GE, Dragova EA. Instruments for disease-specific quality-of-life measurement in patients with type 2 diabetes mellitus–A systemic review. Folia Med (Plovdiv) 2013;55(1):83–92. doi: 10.2478/folmed-2013-0010. https://doi.org/10.1016/j.diabres.2007.12.020. [DOI] [PubMed] [Google Scholar]
  • 5.World Health Organization (WHO) Programme on mental health: WHOQOL measuring quality of life. Geneva: 1997. [Internet] Available from http://www.who.int/mental_health/media/68.pdf. [Google Scholar]
  • 6.Low LL, Tong SF, Low WY. Mixed feelings about the diagnosis of type 2 diabetes mellitus: a consequence of adjusting to health related quality of life. Coll Antropol. 2014;38(1):11–20. [PMC free article] [PubMed] [Google Scholar]
  • 7.Kiadaliri AA, Najafi B, Mirmalek-Sani M. Quality of life in people with diabetes: a systemic review of studies in Iran. J Diabetes Metab Disord. 2013;12(1):54. doi: 10.1186/2251-6581-12-54. https://doi.org/10.1186/2251-6581-12-54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lindsay G, Inverarity K, McDowell JR. Quality of life in people with type 2 diabetes in relation to deprivation, gender, and age in a new community-based mode of care. Nurs Res Pract. 2011;2011:613589. doi: 10.1155/2011/613589. https://doi.org/10.1155/2011/613589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kong D, Ding Y, Zuo X, Su W, Xiu L, Lin M, et al. Adaptation of the audit of diabetes-dependent quality of life questionnaire to people with diabetes in China. Diabetes Res Clin Pract. 2011;94(1):45–52. doi: 10.1016/j.diabres.2011.05.026. https://doi.org/10.1016/j.diabres.2011.05.026. [DOI] [PubMed] [Google Scholar]
  • 10.Shim YT, Lee J, Toh MP, Tang WE, Ko Y. Health-related quality of life and glycemic control in patients with type 2 diabetes mellitus in Singapore. Diabet Med. 2012;29(8):e241–e248. doi: 10.1111/j.1464-5491.2012.03689.x. https://doi.org/10.1111/j.1464-5491.2012.03689.x. [DOI] [PubMed] [Google Scholar]
  • 11.Cheah WL, Lee PY, Lim PY, Fatin Nabila AA, Luk KJ, Nur Irwana AT. Perception of quality of life among people with diabetes. Malays Fam Physician. 2012;7(2–3):21–30. [PMC free article] [PubMed] [Google Scholar]
  • 12.Kamarul Imran M, Aziz AI, Naing L, Wan Mohamad WB. SF-36 and the Malay translated audit of dependent quality of life (ADDQOL-18) performances among type 2 diabetes patients. Jurnal Kesihatan Masyarakat. 2004;10(S):55–58. [Google Scholar]
  • 13.Kamarul Imran M, Ismail AA, Naing L, Wan Mohamad WB. The reliability and validity of the Malay version of the 18-item audit of diabetes dependent quality of life (the Malay ADDQOL-18) questionnaire. Southeast Asian J Trop Med Public Health. 2007;38(2):398–405. [PubMed] [Google Scholar]
  • 14.Pouwer F, Hermanns N. Insulin therapy and quality of life. A review. Diabetes Metab Res Rev. 2009;25(Suppl 1):S4–S10. doi: 10.1002/dmrr.981. https://doi.org/10.1002/dmrr.981. [DOI] [PubMed] [Google Scholar]
  • 15.Sundaram M, Kavookjian J, Patrick JH, Miller LA, Madhavan SS, Scott VG. Quality of life, health status and clinical outcomes in type 2 diabetes patients. Qual Life Res. 2007;16(2):165–177. doi: 10.1007/s11136-006-9105-0. [DOI] [PubMed] [Google Scholar]
  • 16.Scollan-Koliopoulos M, Bleich D, Rapp KJ, Wong P, Hofmann CJ, Raghuwanshi M. Health-related quality of life, disease severity, and anticipated trajectory of diabetes. Diabetes Educ. 2013;39(1):83–91. doi: 10.1177/0145721712467697. https://doi.org/10.1177/0145721712467697. [DOI] [PubMed] [Google Scholar]
  • 17.Chaveepojnkamjorn W, Pichainarong N, Schelp FP, Mahaweerawat U. Quality of life and compliance among type 2 diabetic patients. Southeast Asian J Trop Med Public Health. 2008;39(2):328–334. [PubMed] [Google Scholar]
  • 18.Kamarul Imran M, Ismail AA, Naing L, Wan Mohamad WB. Type 2 diabetes mellitus patients with poor glycemic control have lower quality of life scores as measured by the Short Form-36. Singapore Med J. 2010;51(2):157–162. [PubMed] [Google Scholar]
  • 19.Mazlina M, Shamsul AS, Jeffery FA. Health-related quality of life in patients with diabetic foot problems in Malaysia. Med J Malaysia. 2011;66(3):234–238. [PubMed] [Google Scholar]
  • 20.Gillani SW, Syed Sulaiman SA, Sari YO. Population based survey on knowledge and quality of life perception on erectile dysfunction among diabetic and non-diabetic attributes, Penang Malaysia. Int J Pharm Pharm Sci. 2011;3(Suppl 3):229–234. [Google Scholar]
  • 21.Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQOL-18. Quality of Life Research. 1999;8(1):79–91. doi: 10.1023/a:1026485130100. [DOI] [PubMed] [Google Scholar]
  • 22.Jannoo Z, Yap BW, Musa KI, Lazim MA, Hassali MA. An audit of diabetes-dependent quality of life in patients with type 2 diabetes mellitus in Malaysia. Qual Life Res. 2015;24(9):2297–2302. doi: 10.1007/s11136-015-0969-8. https://doi.org/10.1007/s11136-015-0969-8. [DOI] [PubMed] [Google Scholar]
  • 23.Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009;26:153–161. doi: 10.1111/j.1464-5491.2008.02648.x. https://doi.org/10.1111/j.1464-5491.2008.02648.x. [DOI] [PubMed] [Google Scholar]
  • 24.Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care. 1997;20(4):562–567. doi: 10.2337/diacare.20.4.562. [DOI] [PubMed] [Google Scholar]
  • 25.Demirci H, Cinar Y, Bayram N, Bilgel N. Quality of life in type II diabetic patients in primary health care. Dan Med J. 2012;59(10):A4468. [PubMed] [Google Scholar]
  • 26.Daher AM, Al Mashoor SA, Winn T. Glycaemic control and quality of life among ethnically diverse Malaysian diabetic patients. Qual Life Res. 2015;24(4):951–958. doi: 10.1007/s11136-014-0830-5. https://doi.org/10.1007/s11136-014-0830-5. [DOI] [PubMed] [Google Scholar]
  • 27.Goudswaard AN, Stolk RP, Zuithoff P, de Valk HW, Rutten GE. Starting insulin in type 2 diabetes: continue oral hypoglycemic agents? A randomized trial in primary care. J Fam Pract. 2004;53(5):393–399. [PubMed] [Google Scholar]
  • 28.Ashwell SG, Bradley C, Stephens JW, Witthaus E, Home PD. Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes. Diabetes Care. 2008;31(6):1112–1117. doi: 10.2337/dc07-1183. https://doi.org/10.2337/dc07-1183. [DOI] [PubMed] [Google Scholar]
  • 29.Horvarth K, Jeitler K, Berghold A, Ebrahim SH, Gratzer TW, Plank J, et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Sys Rev. 2007;(2):CD005613. doi: 10.1002/14651858.CD005613.pub3. [DOI] [PubMed] [Google Scholar]
  • 30.Ishii H, Terauchi Y, Jinnouchi H, Taketsuna M, Takeuchi M, Imaoka T. Effects of insulin changes on quality of life and glycemic control in Japanese patients with type 2 diabetes mellitus: the insulin-changing study intending to gain patients’ insights into insulin treatment with patient-reported health outcomes in actual clinical treatments (INSIGHTs) study. J Diabetes Invest. 2013;4(6):560–570. doi: 10.1111/jdi.12086. https://doi.org/10.1111/jdi.12086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Abu Hassan H, Tohid H, Mohd Amin R, Long Bidin MB, Muthupalaniappen L, Omar K. Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration. BMC Family Practice. 2013;14:164. doi: 10.1186/1471-2296-14-164. https://doi.org/10.1186/1471-2296-14-164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ali S, Stone M, Skinner TC, Robertson N, Davies M, Khunti K. The association between depression and health-related quality of life in people with type 2 diabetes: a systematic literature review. Diabetes Metab Res Rev. 2010;26(2):75–89. doi: 10.1002/dmrr.1065. https://doi.org/10.1002/dmrr.1065. [DOI] [PubMed] [Google Scholar]
  • 33.Schram MT, Baan CA, Pouwer F. Depression and quality of life in patients with diabetes: a systematic review from the European Depression in Diabetes (EDID) research consortium. Curr Diabetes Rev. 2009;5(2):112–119. doi: 10.2174/157339909788166828. https://doi.org/10.2174/157339909788166828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care. 1997;20(4):585–590. doi: 10.2337/diacare.20.4.585. [DOI] [PubMed] [Google Scholar]
  • 35.Lloyd C, Smith J, Weinger K. Stress and diabetes: a review of the links. Diabetes Spectrum. 2005;18(2):121–127. https://doi.org/10.2337/diaspect.18.2.121. [Google Scholar]
  • 36.Adegbola M. Spirituality and quality of life in chronic illness. The Journal of Theory Construction & Testing. 2003;10(2):188–189. [Google Scholar]
  • 37.Nabolsi MM, Carson AM. Spirituality, illness and personal responsibility: the experience of Jordanian Muslim men with coronary artery disease. Scand J Caring Sci. 2011;25(4):716–724. doi: 10.1111/j.1471-6712.2011.00882.x. https://doi.org/10.1111/j.1471-6712.2011.00882.x. [DOI] [PubMed] [Google Scholar]

Articles from The Malaysian Journal of Medical Sciences : MJMS are provided here courtesy of School of Medical Sciences, Universiti Sains Malaysia

RESOURCES